Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Trivedi MS, Coe AM, Vanegas A, Kukafka R, Crew KD.

Cancer Prev Res (Phila). 2017 Aug;10(8):434-441. doi: 10.1158/1940-6207.CAPR-17-0100. Epub 2017 Jun 13.

2.

Usability Testing of a Web-Based Decision Aid for Breast Cancer Risk Assessment Among Multi-Ethnic Women.

Coe AM, Ueng W, Vargas JM, David R, Vanegas A, Infante K, Trivedi M, Yi H, Dimond J, Crew KD, Kukafka R.

AMIA Annu Symp Proc. 2017 Feb 10;2016:411-420. eCollection 2016.

3.

Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.

Schroy PC 3rd, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC.

Am J Prev Med. 2012 Dec;43(6):573-83. doi: 10.1016/j.amepre.2012.08.018.

4.

The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy.

Schroy PC 3rd, Coe AM, Mylvaganam SR, Ahn LB, Lydotes MA, Robinson PA, Davis JT, Chen CA, Ashba J, Atkinson ML, Colditz GA, Heeren TC.

Cancer Prev Res (Phila). 2012 Aug;5(8):1044-52. doi: 10.1158/1940-6207.CAPR-12-0014. Epub 2012 Jun 11.

5.

Maternal-fetal glucose gradient in normal pregnancies and in pregnancies complicated by alloimmunization and fetal growth retardation.

Nicolini U, Hubinont C, Santolaya J, Fisk NM, Coe AM, Rodeck CH.

Am J Obstet Gynecol. 1989 Oct;161(4):924-7.

PMID:
2508475

Supplemental Content

Support Center